Back to search

Article

The effectiveness of using escitalopram in pediatric generalized anxiety disorder and the methods to predict the treatment response: A systematic review and meta-analysis

2024-01-03

Abstract excerpt

<h4>Background: </h4> Generalized Anxiety Disorder (GAD) affects approximately 10–15% of children and adolescents. Selective Serotonin Reuptake Inhibitors (SSRIs) are among the main treatment options. Escitalopram, an SSRI for adult anxiety, is being studied for pediatric use. Predicting the treatment response could optimize interventions. This systematic review aimed to understand the safety and efficacy of escit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c97f7c50-34ab-5da9-a578-37552dc7e976
DOI
10.12688/f1000research.143328.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The effectiveness of using escitalopram in pediatric generalized anxiety disorder and the methods to predict the treatment response: A systematic review and meta-analysisDOI 10.12688/f1000research.143328.1
Concerning harm/benefit ratio of escitalopram for pediatric generalized anxiety disorder. A critical viewpoint on the evidence and approval processSemantic proximity
Concerning harm/benefit ratio of escitalopram for pediatric generalized anxiety disorder. A critical viewpoint on the evidence and approval processSemantic proximity
Concerning harm/benefit ratio of escitalopram for pediatric generalized anxiety disorder. A critical viewpoint on the evidence and approval processSemantic proximity
Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysisSemantic proximity
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.Semantic proximity
Gastrointestinal Symptoms in Pediatric Patients with Anxiety Disorders and their Relationship to Treatment with Escitalopram or PlaceboSemantic proximity
ED95 of esketamine for reducing preoperative anxiety in children of different agesSemantic proximity
Variability Exists Across Outcomes Measured and Reported in Studies Assessing Interventions for Generalized Anxiety Disorder During the Perinatal Period: A Scoping ReviewSemantic proximity
Medication Management of Anxiety and Depression by Primary Care Pediatrics Providers: A Retrospective Electronic Health Record StudySemantic proximity
Exploring the Correlation between Seizure Control and Serum Levels of Antiepileptic Drugs in Pediatric Patients with Epilepsy in Ethiopia: A Retrospective Cross-Sectional StudySemantic proximity
Emergence of psychiatric adverse events during antipsychotic treatment in naive children and adolescentsSemantic proximity
Association of SNAP-25, SLC6A2, and LPHN3 with OROS methylphenidate treatment response in attention-deficit/hyperactivity disorder.Semantic proximity
Select a neighboring publication to make it the new centre.